Stock Analysis on Net
Stock Analysis on Net

Merck & Co. Inc. (NYSE:MRK)

$24.99

Income Statement

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Paying users area

Try for free

Merck & Co. Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Merck & Co. Inc., consolidated income statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Sales
Cost of sales
Gross profit
Selling, general and administrative
Research and development
Restructuring costs
Operating income
Interest income
Interest expense
Exchange losses
Income (loss) from investments in equity securities, net
Net periodic defined benefit plan credit other than service cost
Other, net
Other income (expense), net
Income from continuing operations before taxes
Taxes on income from continuing operations
Net income from continuing operations
Income from discontinued operations, net of taxes
Net income
Net (income) loss attributable to noncontrolling interests
Net income attributable to Merck & Co., Inc.

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Sales Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Merck & Co. Inc. sales increased from 2021 to 2022 and from 2022 to 2023.
Operating income The net result for the period of deducting operating expenses from operating revenues. Merck & Co. Inc. operating income increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Income from continuing operations before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Merck & Co. Inc. income from continuing operations before taxes increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Net income attributable to Merck & Co., Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Merck & Co. Inc. net income attributable to Merck & Co., Inc. increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.